Avanos Medical, Inc.
AVNS
$11.28
-$0.30-2.59%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 98.18% | -1,263.64% | 101.66% | -9,339.53% | 138.89% |
| Total Depreciation and Amortization | -6.00% | 4.17% | -13.51% | -5.13% | 3.54% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -88.93% | 1,860.98% | -98.97% | 11,993.94% | -48.44% |
| Change in Net Operating Assets | 57.35% | -225.93% | -88.00% | 1,116.22% | -55.42% |
| Cash from Operations | 105.88% | -73.54% | -55.61% | 151.74% | -17.27% |
| Capital Expenditure | 36.36% | -64.18% | -39.58% | -60.00% | 49.15% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 90.91% | 8.33% | 51.02% | 45.56% | -528.57% |
| Cash from Investing | -138.64% | -45.05% | -19.74% | 36.67% | -103.39% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 4.17% | 91.21% | 0.00% | -106.82% | -780.00% |
| Issuance of Common Stock | -- | -100.00% | -- | -100.00% | -- |
| Repurchase of Common Stock | 100.00% | 63.64% | -2,100.00% | 0.00% | 97.14% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 100.00% | -- |
| Cash from Financing | 37.50% | 89.00% | -6.20% | -71.25% | -220.00% |
| Foreign Exchange rate Adjustments | -110.34% | 61.11% | 142.86% | -333.33% | 460.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -195.52% | 37.38% | -157.22% | 684.38% | -119.51% |